Page last updated: 2024-08-23

azoxymethane and nimesulide

azoxymethane has been researched along with nimesulide in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukutake, M; Ishida, K; Sugimura, T; Takahashi, M; Wakabayashi, K; Yokota, S1
Fukuda, K; Fukutake, M; Isoi, T; Mamiya, S; Nakatsugi, S; Ohta, T; Sato, H; Sugimura, T; Takahashi, M; Taniguchi, Y; Wakabayashi, K1
Kawamori, T; Nakatsugi, S; Wakabayashi, K; Watanabe, K1
Itoh, M; Kawamori, T; Kitamura, T; Matsuura, M; Noda, T; Sugimura, T; Uchiya, N; Wakabayashi, K1
Akedo, H; Baba, M; Higashino, K; Iishi, H; Mukai, M; Tatsuta, M; Yano, H1

Reviews

1 review(s) available for azoxymethane and nimesulide

ArticleYear
COX-2 and iNOS, good targets for chemoprevention of colon cancer.
    BioFactors (Oxford, England), 2000, Volume: 12, Issue:1-4

    Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Colonic Neoplasms; Cyclooxygenase 2; Dinoprostone; Enzyme Inhibitors; Humans; Isoenzymes; Membrane Proteins; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Rats; Receptors, Prostaglandin E; Sulfonamides

2000

Other Studies

4 other study(ies) available for azoxymethane and nimesulide

ArticleYear
Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2.
    Journal of cancer research and clinical oncology, 1996, Volume: 122, Issue:4

    Topics: Animals; Azoxymethane; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Intestinal Mucosa; Isoenzymes; Male; Neoplasms, Experimental; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Sulfonamides

1996
Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice.
    Carcinogenesis, 1998, Volume: 19, Issue:11

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoxymethane; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Male; Mice; Mice, Inbred ICR; Prostaglandin-Endoperoxide Synthases; Sulfonamides

1998
Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis.
    Carcinogenesis, 2002, Volume: 23, Issue:9

    Topics: Animals; Antineoplastic Agents; Azoxymethane; Carcinogenicity Tests; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Female; Genes, APC; Intestinal Neoplasms; Isoenzymes; Isoxazoles; Male; Membrane Proteins; Mice; Mice, Knockout; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Sulfonamides

2002
Suppression by nimesulide of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats.
    Clinical & experimental metastasis, 2003, Volume: 20, Issue:6

    Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoxymethane; Bombesin; Carcinogens; Disease Models, Animal; Intestinal Neoplasms; Lymphatic Metastasis; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Peritoneal Neoplasms; Rats; Rats, Wistar; Sulfonamides

2003